The markets recovered early morning losses to close higher with the Dow rising 46 points to 18,538 as crude oil prices rose. Nasdaq gained 26 points to 5,275.
On the upside
William Blair maintained its Outperform rating on Dynavax Technologies (Nasdaq: DVAX) and said that the Food and Drug Administration's cancellation of an advisory committee meeting for Heplisav was a net positive.
Spectra Energy (NYSE: SE) will be acquired by Enbridge in an all-stock deal valued at approximately $28 billion.
Alibaba Group (NYSE: BABA) executive chair Jack Ma was recognized at the G20 summit for his work promoting easier access to free markets for small and medium-sized enterprises.
On the downside
Karyopharm Therapeutics (Nasdaq: KPTI) reported positive results from a Phase 2b STORM study of selinexor in multiple myeloma but the stock price fell as investors had been anticipating the upbeat results.
Stifel said that the strategic partnership between Navistar (NYSE: NAV) and Volkswagen could negatively impact Cummins (NYSE: CMI).
General Electric (NYSE: GE) will purchase two 3D-printing companies for $1.4 billion.
In the broad market, advancing issues outpaced decliners by a margin of more than 7 to 5 on the NYSE and by more than 10 to 9 on Nasdaq. The broader S&P 500 rose 6 points to 2,186. Bitcoin added $3 to $606.
